+467.0%
MRNA vs GRMN
+21.5%
+445.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GRMN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +4.2% | +1.1% | +3.9% |
| 7D | -1.1% | +2.4% | -3.5% | -1.9% |
| 30D | +126.1% | -8.5% | +134.6% | +133.9% |
| 3M | +190.0% | +19.5% | +170.6% | +161.0% |
| 6M | +157.2% | +21.2% | +136.0% | +128.7% |
| YTD | +388.2% | +41.0% | +347.2% | +289.3% |
| 1Y | +467.0% | +19.6% | +447.4% | +364.9% |
| All | +467.0% | +21.5% | +445.5% | +364.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GRMN.
Daily Out/Under-Performance
Portfolio return minus GRMN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GRMN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GRMN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling